Test blood and antibody markers for suspected acute stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at blood tests to find signs of immune activity after a suspected stroke. It may help doctors diagnose stroke faster and better understand what is happening in the body soon after symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have suspected acute stroke based on a screening check (FAST, LAPSS, or ROSIER score)
- Your stroke symptoms started within the last 24 hours
- You can give informed consent (or a study-approved way of getting consent)
- Recent medical history should not include certain brain-related problems in the last 30 days
- Symptoms should not clearly be more than 24 hours old
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the nervous system's automatic functions (like heart rate and blood pressure) change after a stroke. It uses MRI scans and blood tests to find patterns that might help doctors better understand and treat these changes.
This study looks at blood markers of inflammation in people who have a stroke caused by a blocked vessel and then have a procedure to remove the clot. It aims to see if these markers can predict how well people recover.
This study looks at blood and clot samples from people who have had a stroke to understand how inflammatory cells behave. It may help doctors learn more about why strokes happen and improve treatments in the future.
This study uses blood tests to quickly identify the type of stroke in patients arriving at the emergency room. It aims to help doctors choose the best treatment early on.
This study looks at whether certain blood markers (white blood cell types compared to albumin) can predict how severe a stroke is and how well a person will recover. It may help doctors better understand stroke outcomes, but eligibility is very strict.
This study looks at substances in saliva that might help diagnose or understand stroke. They will compare saliva from people who have had a stroke with saliva from healthy volunteers.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.